States / New York / S 9985

S 9985 In Committee

Enhances transparency in the prescription drug supply chain

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.

Chamber
Senate
Introduced
Apr 21, 2026
Last action
Apr 21, 2026 — REFERRED TO HEALTH
Session
2025-2026
Momentum
26 · Low